Open Access Option

The Journal of Commercial Biotechnology uses a hybrid subscription-based and open access model, serving authors and readers preferring either option.

The elective open access option is available for authors who wish to provide free open access to their papers to enjoy the potential for increased readership and citation associated with open access.

The elective open access option makes select papers freely available, and the annual subscription-access published page count is increased to compensate subscribers. This model provides open access for individual papers, without diluting subscriptions. Authors electing for open access are asked to subsidize this program based on the number of pages in their paper(s).

Pricing for open access is $300 per page. For more information and a price quote, please contact the chief editor at editor@commercialbiotechnology.com.



Copyright © thinkBiotech LLC